Monte Rosa Therapeutics Insider Trades

GLUE

Track insider trading activity from Monte Rosa Therapeutics executives and directors. See which insiders are buying and selling GLUE stock.

Trades Last 12 Months

All Insider Trades for Monte Rosa Therapeutics

Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Bowen Matthew Principal Accounting Officer
Holding Value $279k 25,891 shares
Last Trade
Oct 05, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$137 13 shares
$10.56
$10.76
Warmuth Markus President & CEO
Holding Value $6.3M 585,038 shares
Last Trade
Jul 16, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$220k 9,500 shares
$23.18
$10.76
Champoux Jennifer Chief Operating Officer
Holding Value $290k 26,947 shares
Last Trade
Jul 15, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$102k 4,351 shares
$23.41
$10.76
Townson Sharon Chief Scientific Officer
Holding Value $2.12M 197,290 shares
Last Trade
Jul 06, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$140k 6,000 shares
$23.25
$10.76
Behbahani Ali Director
Holding Value $161k 15,000 shares
Last Trade
Jul 01, 2026 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$360k 15,000 shares
$24.02
$10.76
Janku Filip Chief Medical Officer
Holding Value $710k 66,019 shares
Last Trade
Jun 30, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$131k 5,407 shares
$24.20
$10.76
Holding Value $0 0 shares
Last Trade
Jun 29, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$231k 10,000 shares
$23.11
$10.76
Skvarka Jan Director
Holding Value $278k 25,800 shares
Last Trade
Jun 11, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$441k 25,800 shares
$17.10
$10.76
Hughes Eric A Director
Holding Value $278k 25,800 shares
Last Trade
Jun 11, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$441k 25,800 shares
$17.10
$10.76
Schiff Andrew N Director
Holding Value $278k 25,800 shares
Last Trade
Jun 11, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$441k 25,800 shares
$17.10
$10.76
Siu Christine Director
Holding Value $278k 25,800 shares
Last Trade
Jun 11, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$441k 25,800 shares
$17.10
$10.76
Holding Value $278k 25,800 shares
Last Trade
Jun 11, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$441k 25,800 shares
$17.10
$10.76
Nickson Philip Chief Business & Legal Officer
Holding Value $592k 55,000 shares
Last Trade
Apr 09, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$103k 5,845 shares
$17.69
$10.76
Dunn Edmund Principal Accounting Officer
Holding Value $243k 22,554 shares
Last Trade
Mar 04, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.5k 139 shares
$17.96
$10.76
Schiff Andrew N Director
Holding Value $330k 30,700 shares
Last Trade
Jun 13, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$151k 30,700 shares
$4.91
$10.76
Leo Chandra P. Director
Holding Value $108k 10,000 shares
Last Trade
Mar 24, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$58.4k 10,000 shares
$5.84
$10.76
Holding Value $17.1M 1,589,053 shares
Last Trade
Oct 29, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$622k 67,905 shares
$9.16
$10.76
Wallace Owen B. Chief Scientific Officer
Holding Value $1.28M 119,000 shares
Last Trade
Jan 02, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$679k 119,000 shares
$5.71
$10.76
Jones Jullian G Chief Business Officer
Holding Value $850k 79,000 shares
Last Trade
Jan 02, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$451k 79,000 shares
$5.71
$10.76
Mayweg Alexander Director
Holding Value $221k 20,500 shares
Last Trade
Jun 14, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$135k 20,500 shares
$6.59
$10.76

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up